Project description
Assignment question: What issues do you need to consider when designing a tablet formulation of a new non-sedating antihistamine that has a half-life of 16 hours and

the adult dose will be 2 mg per day?
There is also a need for a liquid formulation for children between the ages of 2 and 12. What factors need to be taken into consideration?

heading suggestion:
1) Introduction.
2) Tablet formulation:
a) patient compliance.
b) pharmaceutics (relationship between a drug, route of administration , how it enters the systemic circulation)
c) pharmacokinetics and physiochemical properties
d) excipients ( what are they? list and function of each?) table
e) stability (stability issues? and solutions?) table
f) dissolution
g) dosing profile

2) liquid formulations
a) solutions
b)excipients
c)stability

3) conclusion

References:
(aulton’s pharmaceutics) **** excipients
(principles and practise of pharmaceutical medicine by Andrew J Fletcher, Lionel D Edwards, Anthony W Fo andPeter Stonier)
other anti-histamine drugs from literature.
(http://books.google.co.uk/books?hl=en&lr=&id=rhglCWal07UC&oi=fnd&pg=PR29&dq=developing+solid+oral+dosage+forms+pharmaceutical+theory+

%26+practice&ots=v1ShBFDJyM&sig=pENYeOCrxQhtgUXAY7oNDq3brRk)